Skin cancer, especially types like basal cell carcinoma (BCCs) and squamous cell carcinoma (SCCs), is a big deal worldwide. Traditional treatments like surgery and radiation can be harsh and not always effective. But there's a new kid on the block: photodynamic therapy (PDT). This method uses specia
Scientists are exploring whether certain immunity signals in the body, known as biomarkers, can forecast the comeback of esophageal squamous cell carcinoma (ESCC) within three years. This type of cancer often returns after patients undergo a mix of treatments including immunotherapy and chemotherapy
Doctors often struggle to predict how long lung cancer patients will live after radiation therapy. This is key for planning personalized treatments. A team recently created a model that uses machine learning to figure this out. They looked at pictures of the lungs and tumor, along with some clinical
Dementia is more than just memory loss; it's a brain condition that alters how people think and live daily. Physiotherapists play a crucial role here, helping patients stay independent and active. But many physios feel they lack the knowledge and confidence to work with dementia patients effectively
Psoriasis patients often worry about developing psoriatic arthritis (PsA). But which biologic treatment is best? Researchers looked at three types: IL-23 inhibitors, IL-17 inhibitors, and IL-12/23 inhibitors, comparing them to TNF inhibitors. The goal? To see who's at higher risk for PsA. First, le
Researchers have been studying a rare condition called Morbihan disease (MD) to better understand how to treat it. They focused on finding new signs that can help predict how well treatment will work. The study also looked at how well a combination of treatments worked in an Asian population. This i
Male germ cell tumors, often called GCT, are quite treatable, with many patients surviving long-term. However, as more people live beyond their cancer diagnosis, doctors are starting to look at the long-term effects of their treatments. One important issue is how male fertility might be affected by
Acalabrutinib, a newer medication for chronic lymphocytic leukemia, is safer than older options. However, managing its side effects can be tricky. A group of French healthcare professionals—including hematologists, pharmacists, and doctors specializing in heart and skin issues—decided to find practi
You know how sometimes people don’t take their medicines as they should? Well, this can be a big problem for folks with heart diseases, especially in places like Mexico, Thailand, and China. A recent study looked into what could happen if these patients took their meds properly. The results? Big sav
At a single hospital, patients with large B-cell lymphoma (LBCL) who didn't respond to initial treatments were given either lisocabtagene maraleucel (liso-cel) or axicabtagene ciloleucel (axi-cel). Liso-cel is newer and not widely studied outside clinical trials yet. From June 2021 to September 2022
